Skip to search boxSkip to navigationSkip to main content

High-altitude pulmonary edema: Diagnosis, prevention, and treatment

  • Andre Pennardt(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

High-altitude pulmonary edema (HAPE) is a lethal, noncardiogenic form of pulmonary edema that afflicts susceptible individuals after rapid ascent to high altitude above 2,500 m. Prevention of HAPE is achieved most effectively by gradual ascent allowing time for proper acclimatization. Certain prophylactic medications may further reduce the risk of ascending to high altitude in individuals with a prior history of HAPE. The most effective and reliable treatment of HAPE is immediate descent and administration of supplemental oxygen.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 115-119 (5 pages)

Journal (Volume, Issue Number)

Current Sports Medicine Reports (Volume 12, Issue 2)

Publication milestones

  • Published - 03/2013

Publication status

Published - 03/2013

ISSN

1537-890X

Publication IDs

  • Scopus: 84877882986
  • PubMed: 23478563

Publication metrics

Metrics

SciVal
FWCI
1.05
SciVal
Author count
1
SciVal
citations
18
SciVal
Paper percentile
78
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
64
Citation count
32